Epigenomics AG Announces Hand-Over of CFO Responsibility by End of Q1 2011

Current CFO Oliver Schacht leaving by March 31, 2011; Experienced CFO Successor to join April 1st, 2011

20-Dec-2010 - Germany

Epigenomics AG announced the scheduled departure of its co-founder and long-standing Chief Financial Officer (CFO) of Epigenomics AG, Oliver Schacht PhD, effective from 31st March 2011.

In his place, the Board has recruited an experienced CFO to take over, effective from 1st April 2011 and has taken measures to ensure a well-planned and structured transition during Q1 2011. Due to confidentiality obligations under the new CFO’s current public company employment, Epigenomics expects to make the announcement of the new CFO in the first weeks of January.

In addition Epigenomics intends to strengthen its commercial operation in the US by recruiting an experienced US-based marketing and sales executive to head the U.S.-based operations, currently run by the departing CFO, and to lead the transformation of that organization into a commercial molecular diagnostics enterprise. With such an addition Epigenomics expects to be well-positioned to drive its U.S. commercialization strategy following an anticipated FDA approval of its colorectal cancer blood test.

Professor Dr. Rolf Krebs, Chairman of Epigenomics AG’s Supervisory Board stated: “On behalf of the Supervisory Board, we thank Oliver for his dedication, professionalism and commitment to Epigenomics. Over the past 12 years, he has been a key member of the team during three rounds of venture capital financing, an IPO, and a trans-Atlantic merger with successful post-merger integration. He is leaving at a time when the Company has been transformed into a much leaner, more effective and efficient commercial diagnostics company. Although we are sorry to be losing Oliver we are fully supportive of his desire to take on a new challenge and we all wish him the best of luck in his new endeavors.”

https://www.bionity.com/en/news/127365/epigenomics-ag-announces-hand-over-of-cfo-responsibility-by-end-of-q1-2011.html